How Vascular Solutions Beat the DOJ & What Medtech Executives Need to Know to Do the Same
May 26, 2016•35 min
Episode description
After five years and $25 million, Vascular Solutions CEO Howard Root watched a jury confirm what he knew all along. His company had done nothing wrong. In this interview, Root and Mark Duval, who is advising companies in this area but didn’t work with Vascular Solutions, explain what all this means for Medtech executives.
For the best experience, listen in Metacast app for iOS or Android
